Methylation of CpG islands at the promoter site has been observed in different tumor cells and has become one of the hallmarks of many cancers because of its ability to silence a number of tumor suppressor genes, including P15INK4b, P16INK4a, P14ARF, CDH1, and other genes [38, 39]. The gene discussed is CDKN2A; the disease is cancer.